Skip to main content
. 2022 May 26;14(11):2223. doi: 10.3390/nu14112223

Table 4.

Changes in anthropometric, metabolic, and liver parameters after 12 months of intervention.

CD (n = 43) MD–HMF
(n = 43)
MD–PA
(n = 42)
p
BMI (kg/m2) Basal 33.6 ± 3.7 34.3 ± 4.0 33.4 ± 3.1 0.006
12 months 31.9 ± 4.1 31.7 ± 4.3 31.8 ± 3.5
Δ −1.7 ± 1.8 *a −2.6 ± 2.2 *a.b −1.6 ± 1.8 *b
Body weight (kg) Basal 92.7 ± 14.4 96.3 ± 13.8 95.3 ± 12.3 0.031
12 months 88.4 ± 14.4 89.5 ± 14.4 91.6 ± 13.0
Δ −4.3 ± 5.5 * −6.8 ± 6.4 *b −3.7 ± 5.0 *b
Body fat (%) Basal 35.2 ± 6.3 35.4 ± 7.2 35.7 ± 7.3 0.737
12 months 33.3 ± 6.1 34.2 ± 9.8 34.9 ± 8.2
Δ −1.9 ± 2.6 * −1.2 ± 8.4 −1.2 ± 7.2
Mass muscle (kg) Basal 57.6 ± 12.2 59.5 ± 8.4 58.7 ± 10.2 0.099
12 months 56.1 ± 11.1 56.1 ± 10.4 57.6 ± 11.0
Δ −1.6 ± 2.5 * −3.3 ± 6.6 * −1.1 ± 2.0 *
Waist circumference (cm) Basal 110.7 ± 9.4 112.1 ± 9.1 112.7 ± 8.5 0.044
12 months 105.0 ± 10.25 104.8 ± 12.0 107.3 ± 9.9
Δ −5.2 ± 6.3 * −7.3 ± 6.2 * −4.1 ± 6.0 *
Physical
activity (MET)
Basal 2750.2 ± 2327.7 3772.4 ± 3275.0 3615.0 ± 4171.1 0.063
12 months 4357.8 ± 4305.6 3440.4 ± 3101.9 4333.1 ± 3849.8
Δ 1607.6 ± 3819.3 * −331.9 ± 3278.9 718.1 ± 4189.2
Glucose (mg/dL) Basal 114.3 ± 36.0 108.7 ± 26.4 118.2 ± 51.9 0.546
12 months 108.2 ± 29.8 100.7 ± 23.1 105.1 ± 18.2
Δ −6.0 ± 16.3 * −8.0 ± 20.2 * −13.1 ± 46.0
Hb1Ac (%) Basal 6.1 ± 1.0 5.9 ± 1.0 6.1 ± 1.5 0.276
12 months 6.0 ± 1.0 5.7 ± 0.7 5.7 ± 0.6
Δ −0.1 ± 0.4 −0.2 ± 0.6 −0.4 ± 1.3
HR (beats/min) Basal 69.4 ± 11.4 67.0 ± 11.4 67.3 ± 8.9 0.541
12 months 63.8 ± 11.1 60.6 ± 11.1 63.7 ± 11.0
Δ −5.6 ± 7.8 * −6.4 ± 7.4 * −3.6 ± 8.3
SBP (mmHg) Basal 136.3 ± 12.7 133.3 ± 14.2 131.9 ± 13.6 0.472
12 months 127.0 ± 15.0 129.1 ± 20.6 125.5 ± 16.6
Δ −9.3 ± 12.9 * −4.2 ± 15.3 −6.4 ± 14.0
DBP (mmHg) Basal 87.7 ± 10.4 88.1 ± 6.7 87.9 ± 6.6 0.875
12 months 80.5 ± 9.1 82.2 ± 8.4 80.9 ± 8.2
Δ −7.2 ± 7.5 * −5.9 ± 10.3 * −7.0 ± 8.5 *
Triglycerides (mg/dL) Basal 186.5 ± 97.8 207.6 ± 330.1 184.4 ± 115.2 0.478
12 months 161.7 ± 108.7 132.0 ± 64.7 148.1 ± 76.5
Δ −24.8 ± 85.5 −75.6 ± 317.0 −36.3 ± 119.2
Total-
cholesterol (mg/dL)
Basal 202.7 ± 43.2 202.7 ± 57.1 196.0 ± 40.6 0.305
12 months 195.0 ± 46.8 183.1 ± 39.6 191.6 ± 40.7
Δ −7.7 ± 33.8 −19.6 ± 63.6 * −4.4 ± 36.8
HDL-chol (mg/dL) Basal 45.5 ± 14.6 46.1 ± 9.0 43.0 ± 9.3 0.560
12 months 47.3 ± 14.2 49.5 ± 11.4 45.4 ± 11.9
Δ 1.8 ± 7.1 3.3 ± 7.4 * 2.4 ± 6.2 *
Intraliver fat contents (%) Basal 14.5 ± 10.1 12.0 ± 12.1 13.5 ± 11.8 0.372
12 months 12.6 ± 9.1 7.1 ± 5.8 10.6 ± 7.7
Δ −1.8 ± 7.6 −4.9 ± 10.6 * −2.9 ± 11.3
Liver stiffness K-pa Basal 5.3 ± 1.7 5.3 ± 1.9 5.3 ± 2.2 0.300
12 months 5.0 ± 1.7 4.8 ± 1.5 5.7 ± 2.4
Δ −0.3 ± 2.1 −0.4 ± 2.2 −0.4 ± 2.8
AST (mg/dL) Basal 28.4 ± 10.1 27.7 ± 17.5 23.9 ± 9.0 0.041
12 months 27.4 ± 17.1 20.9 ± 5.6 22.8 ± 8.8
Δ −1.0 ± 16.0 c −6.8 ± 16.2 −1.1 ± 7.2 *c
ALT (mg/dL) Basal 37.5 ± 20.4 39.4 ± 40.6 33.6 ± 23.1 0.240
12 months 33.4 ± 25.7 25.0 ± 13.0 25.7 ± 16.3
Δ −4.2 ± 28.3 −14.4 ± 36.4 * −8.0 ± 15.1 *
GGT (mg/dL) Basal 47.1 ± 30.3 51.7 ± 71.2 37.5 ± 18.0 0.348
12 months 43.8 ± 44.3 36.3 ± 37.5 31.2 ± 16.4
Δ −3.3 ± 36.3 −15.4 ± 56.4 −6.3 ± 13.0 *

Abbreviations: ALT: alanine aminotransferase; AST: aspartate aminotransferase; BMI: body mass index; CD: Conventional Diet; ∆: change between basal and 12-month data; DBP: Diastolic blood pressure; GGT: gamma-glutamyltransferase; HbA1c: glycated hemoglobin; HDL-c: High density lipoprotein-cholesterol; HR: heart rate; kPa: kilopascals; MD–HMF: Mediterranean diet–high meal frequency; MD–PA: Mediterranean Diet–physical activity (control group); MedDiet: Mediterranean diet; METs: metabolic equivalents; SBP: systolic blood pressure; TG: triglycerides; Total-c: total cholesterol. Data are expressed as mean ± standard deviation (SD). ∆: delta * p < 0.05 Differences between the three intervention groups at 12 months after adjustment for baseline values and age by ANCOVA. Post hoc test by Bonferroni: “a: differences between CD and MD–HMF groups”; “b: differences between MD–PA and MD–HMF”; “c: differences between CD and MD–PA”.